Amatuximab Completed Phase 1 Trials for Mesothelioma / Malignant Neoplasm of Pancreas / Lung Cancer Non-Small Cell Cancer (NSCLC) / Ovarian Cancer Basic Science

IndicationsStatusPurposePhase
CompletedBasic Science1
clinicaltrials.gov IdentifierTitleDrugs
NCT01521325A Single-Dose Pilot Study of Radiolabeled Amatuximab (MORAb-009) in Mesothelin Over Expressing Cancers